Publications by authors named "Koji Mitsuzuka"

Claim this Profile
A
Assessment of Clinicopathological Characteristics and Clinical Outcomes of Patients Who Developed Non-Muscle-Invasive Bladder Cancer After Radiotherapy for Prostate Cancer: A Retrospective Multicenter Study.
Takuma Sato, Takeshi Sano, Hisanobu Adachi, Yoshihiro Ikeda, Jun Takemoto, Koji Mitsuzuka

Tohoku J Exp Med· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improved prognosis of de novo metastatic prostate cancer after an introduction of life-prolonging agents for castration-resistant prostate cancer.
Tokiyoshi Tanegashima, Masaki Shiota, Naoki Terada, Toshihiro Saito, Akira Yokomizo, Koji Mitsuzuka

Int J Clin Oncol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improving compliance with guidelines may lead to favorable clinical outcomes for patients with non-muscle-invasive bladder cancer: A retrospective multicenter study.
Takuma Sato, Takeshi Sano, Sadafumi Kawamura, Yoshihiro Ikeda, Kazuhiko Orikasa, Koji Mitsuzuka

Int J Urol· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trends in the use of local intervention for metastatic hormone-naïve prostate cancer: A multicenter retrospective study.
Ryuma Tanaka, Shingo Hatakeyama, Shintaro Narita, Toshihiko Sakurai, Toshikazu Tanaka, Koji Mitsuzuka

Int J Urol· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of axitinib for metastatic renal cell carcinoma: Real-world data on patients with renal impairment.
Keita Minami, Takahiro Osawa, Takahiro Kojima, Tomohiko Hara, Masatoshi Eto, Koji Mitsuzuka

Urol Oncol· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increasing age predicts adverse pathology including intraductal carcinoma of the prostate and cribriform patterns in deferred radical prostatectomy after upfront active surveillance for Gleason grade group 1 prostate cancer: analysis of prospective observational study cohort.
Yoichiro Tohi, Ryou Ishikawa, Takuma Kato, Jimpei Miyakawa, Ryuji Matsumoto, Koji Mitsuzuka

Jpn J Clin Oncol· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world outcomes of patients with renal cell carcinoma, surgically treated at regional hospitals, based on a prospective long-term survey of the pre-robotic era.
Yoshihide Kawasaki, Hideo Saito, Naomasa Ioritani, Tatsuo Tochigi, Isamu Numata, Koji Mitsuzuka

Int Urol Nephrol· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Laparoscopic Adrenalectomy Is Beneficial for the Health-Related Quality of Life of Older Patients with Primary Aldosteronism.
Yoshihide Kawasaki, Shigeto Ishidoya, Ryo Morimoto, Yoshikiyo Ono, Kei Omata, Koji Mitsuzuka

Urol Int· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical outcomes of intraductal carcinoma or cribriform in radical prostatectomy specimens of men opting for active surveillance: data from the PRIAS-JAPAN study.
Yoichiro Tohi, Ryou Ishikawa, Takuma Kato, Jimpei Miyakawa, Ryuji Matsumoto, Koji Mitsuzuka

Int J Clin Oncol· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Adrenalectomy on Diastolic Cardiac Dysfunction in Patients with Primary Aldosteronism.
Kunihisa Nezu, Yoshihide Kawasaki, Ryo Morimoto, Yoshikiyo Ono, Kei Omata, Koji Mitsuzuka

Tohoku J Exp Med· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Minimal residual membranous urethral length and membranous urethral length predict poor recovery from incontinence after robot-assisted radical prostatectomy and after open radical prostatectomy.
Eiichiro Ohara, Naoki Kawamorita, Yohei Satake, Yasuhiro Kaiho, Koji Mitsuzuka

Int J Urol· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of the medical costs between active surveillance and other treatments for early prostate cancer in Japan using data from the PRIAS-JAPAN study.
Takuma Kato, Akira Yokomizo, Ryuji Matsumoto, Yoichiro Tohi, Jimpei Miyakawa, Koji Mitsuzuka

Int J Urol· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Deliberation on Deferred Cytoreductive Nephrectomy and Postoperative Treatment for Advanced Renal Cell Carcinoma: A Case Report.
Takuya Nakagawa, Yoshihide Kawasaki, Satoko Sato, Hiromichi Katayama, Yohei Satake, Koji Mitsuzuka

Case Rep Oncol· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of adherence to criteria on oncological outcomes of radical prostatectomy in patients opting for active surveillance: data from the PRIAS-JAPAN study.
Yoichiro Tohi, Takuma Kato, Jimpei Miyakawa, Ryuji Matsumoto, Hiroshi Sasaki, Koji Mitsuzuka

Jpn J Clin Oncol· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of upfront intensive therapy on oncological outcomes in older patients with high tumor burden metastatic castration-sensitive prostate cancer: A multicenter retrospective study.
Yuki Miura, Shingo Hatakeyama, Shintaro Narita, Takahiro Kimura, Kenichi Hata, Koji Mitsuzuka

Prostate· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Severe Inflammatory Idiopathic Multicentric Castleman's Disease Coexisting with Advanced Renal Cancer: A Case Report.
Daigo Chiba, Yoshihide Kawasaki, Atsushi Miyagi, Yuki Katsumata, Yohei Satake, Koji Mitsuzuka

Tohoku J Exp Med· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of combined androgen blockade therapy in patients with metastatic hormone-sensitive prostate cancer stratified by tumor burden.
Yoshiyuki Nagumo, Mizuki Onozawa, Takahiro Kojima, Naoki Terada, Masaki Shiota, Koji Mitsuzuka

Int J Urol· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reclassification prediction of first-year protocol biopsy on active surveillance of prostate cancer by p2PSA-related parameters: from PRIAS-JAPAN.
Takuma Kato, Hiromi Hirama, Koji Mitsuzuka, Satoru Maruyama, Hiroshi Sasaki

Prostate Cancer Prostatic Dis· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Gleason pattern 5 on prognosis for newly diagnosed metastatic hormone-sensitive prostate cancer with Gleason score ≥8.
Kento Morozumi, Koji Mitsuzuka, Shintaro Narita, Masahiro Takahashi, Sadafumi Kawamura

Int J Urol· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: The impact of complications after initial prostate biopsy on repeat protocol biopsy acceptance rate. Results from the Prostate Cancer Research International: Active Surveillance JAPAN study.
Yoichiro Tohi, Takuma Kato, Ryuji Matsumoto, Nobuo Shinohara, Kenichiro Shiga, Koji Mitsuzuka

Int J Clin Oncol· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Deferred radical prostatectomy in patients who initially elected for active surveillance: a multi-institutional, prospective, observational cohort of the PRIAS-JAPAN study.
Yoichiro Tohi, Takuma Kato, Masaki Nakamura, Ryuji Matsumoto, Hiroshi Sasaki, Koji Mitsuzuka

Int J Clin Oncol· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictive model for recurrence of renal cell carcinoma by comparing pre- and postoperative urinary metabolite concentrations.
Kento Morozumi, Yoshihide Kawasaki, Masamitsu Maekawa, Shinya Takasaki, Tomonori Sato, Koji Mitsuzuka

Cancer Sci· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characteristics of α2,3-sialyl N-glycosylated PSA as a biomarker for clinically significant prostate cancer in men with elevated PSA level.
Tohru Yoneyama, Hayato Yamamoto, Mihoko Sutoh Yoneyama, Yuki Tobisawa, Shingo Hatakeyama, Koji Mitsuzuka

Prostate· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combination Therapy of Pembrolizumab plus Axitinib for a Patient on Hemodialysis with Metastatic Renal Cell Carcinoma: A Case Report.
Yuki Katsumata, Yoshihide Kawasaki, Kayu Tanaka, Daisuke Nakayama, Hiromichi Katayama, Koji Mitsuzuka

Case Rep Oncol· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical predictors of severe late urinary toxicity after curative intensity-modulated radiation therapy for localized prostate cancer.
Ken Takeda, Rei Umezawa, Yojiro Ishikawa, Takaya Yamamoto, Noriyoshi Takahashi, Koji Mitsuzuka

J Radiat Res· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis